Suzhou Transcenta Therapeutics Co., Ltd.

This is the first study in people testing a new drug called TST003 for patients with advanced solid tumors that have spread or cannot be removed by surgery. The main goals are to find a safe dose, check for side effects, and see if the drug can help shrink tumors, especially in c…

This early-stage trial is testing a new drug called TST001 for people with advanced stomach, gastroesophageal junction, or pancreatic cancer. The main goals are to find a safe dose and see how well the body handles the drug, both alone and when combined with other standard cancer…